AG˹ٷ

STOCK TITAN

[Form 4] National Vision Holdings, Inc. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

National Vision Holdings, Inc. (EYE) � Form 4 filing dated 06/23/2025

Director Susan C. O’Farrell reported the award of 9,674 restricted stock units (RSUs) on 06/18/2025. Each RSU converts into one share of common stock and will vest 100 % on the first anniversary of the grant date. The grant was recorded at $0 acquisition cost, indicating it is an equity-based compensation award rather than an open-market purchase.

Following the grant, O’Farrell’s total beneficial ownership increased to 22,333 shares, all held directly. No derivative securities or sales were disclosed. The transaction modestly increases insider alignment with shareholders, while the share count involved is immaterial relative to EYE’s outstanding shares and therefore has no meaningful dilutive impact.

National Vision Holdings, Inc. (EYE) � Comunicazione Form 4 del 23/06/2025

La direttrice Susan C. O’Farrell ha riportato la concessione di 9.674 unità azionarie vincolate (RSU) in data 18/06/2025. Ogni RSU si converte in un’azione ordinaria e maturerà per intero (100%) al primo anniversario della data di assegnazione. Il premio è stato registrato con un costo di acquisizione pari a $0, segnalando che si tratta di una remunerazione basata su azioni e non di un acquisto sul mercato aperto.

A seguito dell’assegnazione, la proprietà beneficiaria totale di O’Farrell è aumentata a 22.333 azioni, tutte detenute direttamente. Non sono stati segnalati titoli derivati né vendite. L’operazione aumenta leggermente l’allineamento degli insider con gli azionisti, mentre il numero di azioni coinvolte è irrilevante rispetto alle azioni in circolazione di EYE e pertanto non ha alcun impatto diluitivo significativo.

National Vision Holdings, Inc. (EYE) � Presentación del Formulario 4 fechada el 23/06/2025

La directora Susan C. O’Farrell informó la concesión de 9,674 unidades de acciones restringidas (RSU) el 18/06/2025. Cada RSU se convierte en una acción común y se consolidará en un 100% en el primer aniversario de la fecha de otorgamiento. La concesión se registró con un costo de adquisición de $0, indicando que es una compensación basada en acciones y no una compra en el mercado abierto.

Tras la concesión, la propiedad beneficiaria total de O’Farrell aumentó a 22,333 acciones, todas mantenidas directamente. No se divulgaron valores derivados ni ventas. La transacción incrementa modestamente la alineación de los insiders con los accionistas, mientras que el número de acciones involucradas es insignificante en relación con las acciones en circulación de EYE y, por lo tanto, no tiene ningún impacto dilutivo significativo.

National Vision Holdings, Inc. (EYE) � 2025� 6� 23일자 Form 4 제출

이사 Susan C. O’Farrell가 2025� 6� 18일에 9,674개의 제한주식단위(RSU) 수여� 보고했습니다. � RSU� 보통� 1주로 전환되며 수여일로부� 1� � 100% 완전 취득됩니�. � 수여� 취득 비용 $0� 기록되어, 공개 시장 매수가 아닌 주식 기반 보상임을 나타냅니�.

수여 � O’Farrell� � 실질 소유 주식 수는 22,333�� 증가했으� 모두 직접 보유 중입니다. 파생 증권이나 매도 내역은 공개되지 않았습니�. 이번 거래� 내부자와 주주 간의 이해관� 일치� 소폭 높이지�, 해당 주식 수는 EYE� 발행 주식 대� 미미� 수준으로 중대� 희석 효과� 없습니다.

National Vision Holdings, Inc. (EYE) � Dépôt du Formulaire 4 daté du 23/06/2025

La directrice Susan C. O’Farrell a déclaré l�attribution de 9 674 unités d’actions restreintes (RSU) le 18/06/2025. Chaque RSU se convertit en une action ordinaire et sera acquise à 100 % à la première date anniversaire de la date d’attribution. L’attribution a été enregistrée avec un coût d’acquisition de 0 $, indiquant qu’il s’agit d’une rémunération en actions plutôt que d’un achat sur le marché libre.

Suite à cette attribution, la détention bénéficiaire totale d’O’Farrell a augmenté à 22 333 actions, toutes détenues directement. Aucun titre dérivé ni vente n’a été divulgué. La transaction augmente modestement l’alignement des intérêts des initiés avec ceux des actionnaires, tandis que le nombre d’actions concernées est é𲹲 par rapport aux actions en circulation d’EYE et n’a donc aucun impact dilutif significatif.

National Vision Holdings, Inc. (EYE) � Form 4 Einreichung vom 23.06.2025

Direktorin Susan C. O’Farrell meldete die Zuteilung von 9.674 Restricted Stock Units (RSUs) am 18.06.2025. Jede RSU wandelt sich in eine Stammaktie um und wird zu 100 % am ersten Jahrestag des Zuteilungsdatums fällig. Die Zuteilung wurde mit 0 $ Anschaffungskosten verbucht, was darauf hinweist, dass es sich um eine aktienbasierte Vergütung und keinen Kauf am freien Markt handelt.

Nach der Zuteilung erhöhte sich O’Farrells gesamtes wirtschaftliches Eigentum auf 22.333 Aktien, alle direkt gehalten. Es wurden keine Derivate oder Verkäufe offengelegt. Die Transaktion erhöht die Interessenangleichung der Insider mit den Aktionären leicht, während die Anzahl der beteiligten Aktien im Verhältnis zu den ausstehenden EYE-Aktien unwesentlich ist und daher keine nennenswerte Verwässerung bewirkt.

Positive
  • Director increased beneficial ownership by 9,674 shares, enhancing alignment between board and shareholders.
  • No shares were sold; the filing signals commitment rather than profit-taking.
Negative
  • Slight share dilution will occur when RSUs vest, though the impact is immaterial.

Insights

TL;DR: Routine director RSU grant; improves alignment, negligible dilution—overall neutral-to-slightly positive.

The Form 4 shows a standard annual equity grant to an outside director. With 9,674 RSUs (�0.01 % of shares outstanding), the award is well within typical board compensation benchmarks. Because the shares vest in one year, they serve as a retention tool and link compensation to share performance. No sales, options, or complex derivatives are involved, so no negative governance signal arises. From a valuation standpoint, the incremental dilution is immaterial, and the filing does not alter the investment thesis. I therefore classify the impact as neutral, edging positive for governance alignment.

National Vision Holdings, Inc. (EYE) � Comunicazione Form 4 del 23/06/2025

La direttrice Susan C. O’Farrell ha riportato la concessione di 9.674 unità azionarie vincolate (RSU) in data 18/06/2025. Ogni RSU si converte in un’azione ordinaria e maturerà per intero (100%) al primo anniversario della data di assegnazione. Il premio è stato registrato con un costo di acquisizione pari a $0, segnalando che si tratta di una remunerazione basata su azioni e non di un acquisto sul mercato aperto.

A seguito dell’assegnazione, la proprietà beneficiaria totale di O’Farrell è aumentata a 22.333 azioni, tutte detenute direttamente. Non sono stati segnalati titoli derivati né vendite. L’operazione aumenta leggermente l’allineamento degli insider con gli azionisti, mentre il numero di azioni coinvolte è irrilevante rispetto alle azioni in circolazione di EYE e pertanto non ha alcun impatto diluitivo significativo.

National Vision Holdings, Inc. (EYE) � Presentación del Formulario 4 fechada el 23/06/2025

La directora Susan C. O’Farrell informó la concesión de 9,674 unidades de acciones restringidas (RSU) el 18/06/2025. Cada RSU se convierte en una acción común y se consolidará en un 100% en el primer aniversario de la fecha de otorgamiento. La concesión se registró con un costo de adquisición de $0, indicando que es una compensación basada en acciones y no una compra en el mercado abierto.

Tras la concesión, la propiedad beneficiaria total de O’Farrell aumentó a 22,333 acciones, todas mantenidas directamente. No se divulgaron valores derivados ni ventas. La transacción incrementa modestamente la alineación de los insiders con los accionistas, mientras que el número de acciones involucradas es insignificante en relación con las acciones en circulación de EYE y, por lo tanto, no tiene ningún impacto dilutivo significativo.

National Vision Holdings, Inc. (EYE) � 2025� 6� 23일자 Form 4 제출

이사 Susan C. O’Farrell가 2025� 6� 18일에 9,674개의 제한주식단위(RSU) 수여� 보고했습니다. � RSU� 보통� 1주로 전환되며 수여일로부� 1� � 100% 완전 취득됩니�. � 수여� 취득 비용 $0� 기록되어, 공개 시장 매수가 아닌 주식 기반 보상임을 나타냅니�.

수여 � O’Farrell� � 실질 소유 주식 수는 22,333�� 증가했으� 모두 직접 보유 중입니다. 파생 증권이나 매도 내역은 공개되지 않았습니�. 이번 거래� 내부자와 주주 간의 이해관� 일치� 소폭 높이지�, 해당 주식 수는 EYE� 발행 주식 대� 미미� 수준으로 중대� 희석 효과� 없습니다.

National Vision Holdings, Inc. (EYE) � Dépôt du Formulaire 4 daté du 23/06/2025

La directrice Susan C. O’Farrell a déclaré l�attribution de 9 674 unités d’actions restreintes (RSU) le 18/06/2025. Chaque RSU se convertit en une action ordinaire et sera acquise à 100 % à la première date anniversaire de la date d’attribution. L’attribution a été enregistrée avec un coût d’acquisition de 0 $, indiquant qu’il s’agit d’une rémunération en actions plutôt que d’un achat sur le marché libre.

Suite à cette attribution, la détention bénéficiaire totale d’O’Farrell a augmenté à 22 333 actions, toutes détenues directement. Aucun titre dérivé ni vente n’a été divulgué. La transaction augmente modestement l’alignement des intérêts des initiés avec ceux des actionnaires, tandis que le nombre d’actions concernées est é𲹲 par rapport aux actions en circulation d’EYE et n’a donc aucun impact dilutif significatif.

National Vision Holdings, Inc. (EYE) � Form 4 Einreichung vom 23.06.2025

Direktorin Susan C. O’Farrell meldete die Zuteilung von 9.674 Restricted Stock Units (RSUs) am 18.06.2025. Jede RSU wandelt sich in eine Stammaktie um und wird zu 100 % am ersten Jahrestag des Zuteilungsdatums fällig. Die Zuteilung wurde mit 0 $ Anschaffungskosten verbucht, was darauf hinweist, dass es sich um eine aktienbasierte Vergütung und keinen Kauf am freien Markt handelt.

Nach der Zuteilung erhöhte sich O’Farrells gesamtes wirtschaftliches Eigentum auf 22.333 Aktien, alle direkt gehalten. Es wurden keine Derivate oder Verkäufe offengelegt. Die Transaktion erhöht die Interessenangleichung der Insider mit den Aktionären leicht, während die Anzahl der beteiligten Aktien im Verhältnis zu den ausstehenden EYE-Aktien unwesentlich ist und daher keine nennenswerte Verwässerung bewirkt.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
OFarrell Susan C

(Last) (First) (Middle)
2435 COMMERCE AVENUE
BUILDING 2200

(Street)
DULUTH GA 30096

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
National Vision Holdings, Inc. [ EYE ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/18/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/18/2025 A 9,674(1) A $0 22,333 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of National Vision Holdings, Inc. common stock. The RSUs vest in full on the first anniversary of the date of grant.
Remarks:
/s/ Jared Brandman, as Attorney-in-Fact 06/23/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did National Vision (EYE) disclose in the 06/23/2025 Form 4?

Director Susan C. O’Farrell received 9,674 RSUs granted on 06/18/2025.

How many EYE shares does Susan C. O’Farrell now own?

After the grant, she beneficially owns 22,333 shares of common stock.

When do the newly granted RSUs for EYE vest?

The RSUs vest in full one year after the grant date (06/18/2026).

Was there any sale of EYE shares in this Form 4 filing?

No; the filing reports only an acquisition via RSU grant.

Does the RSU grant meaningfully dilute existing EYE shareholders?

Dilution is immaterial given the small share count relative to EYE’s total outstanding shares.
National Vision

NASDAQ:EYE

EYE Rankings

EYE Latest News

EYE Latest SEC Filings

EYE Stock Data

1.94B
77.24M
2.13%
105.42%
6.95%
Specialty Retail
Ophthalmic Goods
United States
DULUTH